Veeva Systems Inc. (NYSE:VEEV - Free Report) - Research analysts at Zacks Research upped their Q2 2026 EPS estimates for shares of Veeva Systems in a report issued on Wednesday, March 26th. Zacks Research analyst R. Department now forecasts that the technology company will post earnings of $1.22 per share for the quarter, up from their previous estimate of $1.14. The consensus estimate for Veeva Systems' current full-year earnings is $4.35 per share. Zacks Research also issued estimates for Veeva Systems' Q3 2026 earnings at $1.33 EPS, Q4 2026 earnings at $1.31 EPS, Q1 2027 earnings at $1.32 EPS and Q2 2027 earnings at $1.35 EPS.
A number of other brokerages have also recently commented on VEEV. Truist Financial increased their target price on shares of Veeva Systems from $210.00 to $217.00 and gave the company a "hold" rating in a research report on Thursday, March 6th. Robert W. Baird upped their price target on Veeva Systems from $283.00 to $285.00 and gave the company an "outperform" rating in a research report on Thursday, March 6th. Bank of America lifted their price objective on Veeva Systems from $280.00 to $290.00 and gave the stock a "neutral" rating in a research report on Friday, December 6th. Scotiabank raised their target price on Veeva Systems from $240.00 to $245.00 and gave the stock a "sector perform" rating in a research note on Thursday, March 6th. Finally, StockNews.com raised shares of Veeva Systems from a "hold" rating to a "buy" rating in a research report on Monday, February 17th. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and sixteen have assigned a buy rating to the company's stock. According to data from MarketBeat, Veeva Systems presently has an average rating of "Moderate Buy" and a consensus price target of $256.52.
Check Out Our Latest Analysis on Veeva Systems
Veeva Systems Stock Down 1.1 %
Shares of NYSE VEEV traded down $2.56 during midday trading on Friday, hitting $231.65. The stock had a trading volume of 1,268,958 shares, compared to its average volume of 1,038,842. The stock has a 50 day simple moving average of $231.62 and a 200-day simple moving average of $222.87. The company has a market capitalization of $37.61 billion, a PE ratio of 57.20, a P/E/G ratio of 1.89 and a beta of 0.88. Veeva Systems has a 1 year low of $170.25 and a 1 year high of $258.93.
Institutional Trading of Veeva Systems
Hedge funds and other institutional investors have recently made changes to their positions in the stock. MassMutual Private Wealth & Trust FSB raised its holdings in Veeva Systems by 72.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company's stock worth $25,000 after purchasing an additional 50 shares in the last quarter. Centricity Wealth Management LLC bought a new stake in shares of Veeva Systems in the 4th quarter worth $25,000. Smithfield Trust Co raised its stake in shares of Veeva Systems by 145.5% in the 4th quarter. Smithfield Trust Co now owns 135 shares of the technology company's stock worth $27,000 after buying an additional 80 shares in the last quarter. True Wealth Design LLC lifted its holdings in shares of Veeva Systems by 3,375.0% in the third quarter. True Wealth Design LLC now owns 139 shares of the technology company's stock valued at $29,000 after buying an additional 135 shares during the period. Finally, Avion Wealth boosted its stake in Veeva Systems by 635.0% during the fourth quarter. Avion Wealth now owns 147 shares of the technology company's stock valued at $30,000 after buying an additional 127 shares in the last quarter. 88.20% of the stock is currently owned by institutional investors.
Veeva Systems Company Profile
(
Get Free Report)
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Recommended Stories
Before you consider Veeva Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veeva Systems wasn't on the list.
While Veeva Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
